Healthcare provider profile · identity verified

Vu Ngo, MD

Family Practice · LIVERMORE, CA · NPI 1255350930

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	431	163
Losartan Potassium	Losartan Potassium	325	125
Amlodipine Besylate	Amlodipine Besylate	286	111
Lisinopril	Lisinopril	228	89
Levothyroxine Sodium	Levothyroxine Sodium	197	75
Tamsulosin Hcl	Tamsulosin Hcl	130	53
Metformin Hcl	Metformin Hcl	117	47
Atenolol	Atenolol	107	42
Simvastatin	Simvastatin	107	40
Hydrochlorothiazide	Hydrochlorothiazide	105	45
Glipizide	Glipizide	99	41
Alendronate Sodium	Alendronate Sodium	98	36
Gabapentin	Gabapentin	93	49
Metoprolol Tartrate	Metoprolol Tartrate	91	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	27
Fluticasone Propionate	Fluticasone Propionate	76	27
Rosuvastatin Calcium	Rosuvastatin Calcium	75	27
Famotidine	Famotidine	68	22
Ibuprofen	Ibuprofen	68	41
Metoprolol Succinate	Metoprolol Succinate	68	25
Lovastatin	Lovastatin	66	23
Allopurinol	Allopurinol	61	22
Albuterol Sulfate Hfa	Albuterol Sulfate	53	38
Furosemide	Furosemide	52	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	25
Alvesco	Ciclesonide	46	24
Spiriva Respimat	Tiotropium Bromide	45	17
Jardiance	Empagliflozin	44	15
Omeprazole	Omeprazole	43	18
Pravastatin Sodium	Pravastatin Sodium	42	14
Pantoprazole Sodium	Pantoprazole Sodium	39	17
Tramadol Hcl	Tramadol Hcl	39	14
Hydralazine Hcl	Hydralazine Hcl	38	16
Metformin Hcl Er	Metformin Hcl	37	15
Terazosin Hcl	Terazosin Hcl	35	13
Amoxicillin	Amoxicillin	33	15
Trazodone Hcl	Trazodone Hcl	32	12
Baclofen	Baclofen	31	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	14
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Humulin N	Insulin Nph Human Isophane	30	14
Citalopram Hbr	Citalopram Hydrobromide	29	12
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Carvedilol	Carvedilol	26	15
Prednisone	Prednisone	26	23
Montelukast Sodium	Montelukast Sodium	25	12
Glipizide Er	Glipizide	24	suppressed
Acyclovir	Acyclovir	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	15
Wixela Inhub	Fluticasone Propion/Salmeterol	22	12
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Finasteride	Finasteride	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Colchicine	Colchicine	19	12
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluocinonide	Fluocinonide	18	13
Nystatin	Nystatin	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Azithromycin	Azithromycin	17	17
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	11
Ozempic	Semaglutide	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lactulose	Lactulose	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	14	14
Azelastine Hcl	Azelastine Hcl	14	suppressed
Cephalexin	Cephalexin	14	13
Fenofibrate	Fenofibrate	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Clonazepam	Clonazepam	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error